Free Trial

Polianta Ltd Acquires New Holdings in Globe Life Inc. (NYSE:GL)

Globe Life logo with Finance background

Polianta Ltd acquired a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,200 shares of the company's stock, valued at approximately $1,249,000.

A number of other large investors also recently bought and sold shares of the business. Versant Capital Management Inc grew its position in shares of Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company's stock worth $27,000 after buying an additional 194 shares during the last quarter. Riverview Trust Co acquired a new stake in shares of Globe Life in the 3rd quarter worth $32,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of Globe Life by 88.4% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 599 shares of the company's stock worth $50,000 after purchasing an additional 281 shares in the last quarter. True Wealth Design LLC purchased a new position in Globe Life during the 3rd quarter worth $59,000. Finally, Quarry LP increased its position in Globe Life by 47.5% during the 2nd quarter. Quarry LP now owns 838 shares of the company's stock valued at $69,000 after buying an additional 270 shares in the last quarter. Institutional investors own 81.61% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on GL. Keefe, Bruyette & Woods boosted their price target on Globe Life from $135.00 to $137.00 and gave the stock an "outperform" rating in a research note on Friday, January 10th. Raymond James upped their price target on shares of Globe Life from $160.00 to $188.00 and gave the company a "strong-buy" rating in a research note on Tuesday, October 15th. Wells Fargo & Company lifted their price objective on shares of Globe Life from $108.00 to $117.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. TD Cowen began coverage on Globe Life in a research report on Wednesday, October 9th. They set a "buy" rating and a $150.00 price target for the company. Finally, Piper Sandler increased their price objective on Globe Life from $118.00 to $130.00 and gave the company an "overweight" rating in a report on Friday, October 25th. Four equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Globe Life has an average rating of "Moderate Buy" and a consensus target price of $134.00.

Get Our Latest Report on Globe Life

Insider Transactions at Globe Life

In other news, Director Mark A. Blinn sold 3,000 shares of the business's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the transaction, the director now owns 5,122 shares of the company's stock, valued at approximately $579,964.06. The trade was a 36.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CMO Jennifer Allison Haworth sold 9,000 shares of Globe Life stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the transaction, the chief marketing officer now directly owns 13,485 shares in the company, valued at $1,522,591.35. This trade represents a 40.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,788 shares of company stock valued at $4,429,779 over the last 90 days. 1.51% of the stock is currently owned by corporate insiders.

Globe Life Stock Performance

GL traded up $1.23 on Monday, reaching $118.47. The stock had a trading volume of 418,802 shares, compared to its average volume of 687,880. The business's 50-day moving average price is $109.90 and its two-hundred day moving average price is $103.40. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $132.00. The company has a market cap of $9.94 billion, a P/E ratio of 10.02 and a beta of 0.80.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.06 by $0.43. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.46 billion. During the same quarter last year, the company earned $2.71 EPS. The firm's revenue for the quarter was up 5.1% compared to the same quarter last year. Sell-side analysts forecast that Globe Life Inc. will post 12.32 earnings per share for the current year.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Monday, January 6th will be issued a $0.24 dividend. The ex-dividend date is Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a yield of 0.81%. Globe Life's payout ratio is currently 8.12%.

Globe Life Company Profile

(Free Report)

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Further Reading

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines